Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Intangibles (2016 - 2025)

Historic Intangibles for China Pharma Holdings (CPHI) over the last 17 years, with Q3 2025 value amounting to $8.8 million.

  • China Pharma Holdings' Intangibles rose 10117.03% to $8.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.8 million, marking a year-over-year increase of 10117.03%. This contributed to the annual value of $6.7 million for FY2024, which is 10568.23% up from last year.
  • As of Q3 2025, China Pharma Holdings' Intangibles stood at $8.8 million, which was up 10117.03% from $6.4 million recorded in Q2 2025.
  • In the past 5 years, China Pharma Holdings' Intangibles ranged from a high of $8.8 million in Q3 2025 and a low of $106788.0 during Q3 2022
  • For the 5-year period, China Pharma Holdings' Intangibles averaged around $3.6 million, with its median value being $4.4 million (2024).
  • Its Intangibles has fluctuated over the past 5 years, first skyrocketed by 273599.66% in 2021, then plummeted by 9794.85% in 2022.
  • Over the past 5 years, China Pharma Holdings' Intangibles (Quarter) stood at $147841.0 in 2021, then soared by 1122.59% to $1.8 million in 2022, then soared by 80.1% to $3.3 million in 2023, then soared by 105.68% to $6.7 million in 2024, then soared by 31.06% to $8.8 million in 2025.
  • Its last three reported values are $8.8 million in Q3 2025, $6.4 million for Q2 2025, and $6.6 million during Q1 2025.